CACNG1 Gene - Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1

CACNG1 Gene - Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1

Introduction

<div class="infobox infobox-gene">
<h3>CACNG1</h3>
<table>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1</td></tr>
<tr><th>Chromosomal Location</th><td>17q24</td></tr>
<tr><th>NCBI Gene ID</th><td>[11052](https://www.ncbi.nlm.nih.gov/gene/11052)</td></tr>
<tr><th>UniProt</th><td>[Q9Y698](https://www.uniprot.org/uniprot/Q9Y698)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000096433</td></tr>
<tr><th>Protein</th><td>Voltage-dependent calcium channel gamma-1 subunit</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Epilepsy, Neuromuscular Disorders</td></tr>
</table>
</div>

Overview

CACNG1 (Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1) encodes the gamma-1 subunit of voltage-gated calcium channels (VGCCs). Located on chromosome 17q24, this gene produces a membrane-associated protein that functions as an auxiliary (regulatory) subunit of L-type voltage-gated calcium channels[@awa2018], [@pierce2020]. While traditionally studied in the context of muscle physiology, increasing evidence points to important roles for CACNG1 and related gamma subunits in neuronal calcium signaling and neurodegenerative disease pathogenesis[@gomez2021], [@erickson2021].

CACNG1 Gene - Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1

Introduction

<div class="infobox infobox-gene">
<h3>CACNG1</h3>
<table>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1</td></tr>
<tr><th>Chromosomal Location</th><td>17q24</td></tr>
<tr><th>NCBI Gene ID</th><td>[11052](https://www.ncbi.nlm.nih.gov/gene/11052)</td></tr>
<tr><th>UniProt</th><td>[Q9Y698](https://www.uniprot.org/uniprot/Q9Y698)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000096433</td></tr>
<tr><th>Protein</th><td>Voltage-dependent calcium channel gamma-1 subunit</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Epilepsy, Neuromuscular Disorders</td></tr>
</table>
</div>

Overview

CACNG1 (Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1) encodes the gamma-1 subunit of voltage-gated calcium channels (VGCCs). Located on chromosome 17q24, this gene produces a membrane-associated protein that functions as an auxiliary (regulatory) subunit of L-type voltage-gated calcium channels[@awa2018], [@pierce2020]. While traditionally studied in the context of muscle physiology, increasing evidence points to important roles for CACNG1 and related gamma subunits in neuronal calcium signaling and neurodegenerative disease pathogenesis[@gomez2021], [@erickson2021].

Calcium influx through voltage-gated channels is fundamental to neuronal function, driving processes including neurotransmitter release, gene transcription, synaptic plasticity, and activity-dependent survival signaling[@calcium2017]. The auxiliary gamma subunits modulate these channels in ways that critically influence neuronal calcium dynamics, making them relevant to understanding neurodegeneration[@snider2018].

Protein Structure and Function

Structure of the Gamma-1 Subunit

The CACNG1 protein (~33 kDa) belongs to the TM4S (tetrahelix transmembrane-spanning 4) protein family, characterized by four transmembrane domains with intracellular N- and C-termini[@pierce2020], [@bergerton2019]:

• First transmembrane domain (TM1): Contributes to channel subunit interaction interface
• Second transmembrane domain (TM2): Forms the core of the channel pore (with gamma-1 specifically)
• Third transmembrane domain (TM3): Involves subunit-subunit contacts
• Fourth transmembrane domain (TM4): Participates in membrane-spanning region
• Loop regions: Major extracellular loop between TM1 and TM2 contains N-linked glycosylation sites
• C-terminal tail: Intracellular domain involved in protein-protein interactions and modulation

Channel Complex Assembly

L-type calcium channels are macromolecular complexes comprising multiple subunits[@pierce2020], [@synapt2020]:

The alpha-1 subunit (Cav1.2 or Cav1.3 for neuronal L-type channels) forms the transmembrane pore and contains:

• Voltage sensor (S1-S4 domains)
• Selectivity filter (pore loop between S5-S6)
• Calmodulin binding site (C-terminal)
• Beta subunit interaction domain (AID pocket in I-II loop)

Functional Effects of Gamma-1

Gamma subunits modulate L-type channel function through several mechanisms[@awa2018], [@duprat2018]:

Specific to neuronal L-type channels, CACNG1 modulates calcium influx in ways that affect:

• Synaptic input integration
• Dendritic spike generation
• Gene transcription (via calcium-dependent signaling)
• Neuronal survival/death decisions

Role in Calcium Homeostasis and Neuronal Function

Calcium Dynamics in Neurons

Calcium acts as a ubiquitous second messenger in neurons, with spatially and temporally controlled signals governing diverse outcomes[@calcium2017], [@chan2018]:

• Synaptic terminals: Rapid calcium influx (milliseconds) triggers neurotransmitter release via synaptotagmin and SNARE proteins
• Dendritic spines: Synaptically evoked calcium signals mediate synaptic plasticity (LTP/LTD)
• Soma and dendrites: Calcium-activated kinases (CaMKII, PKC, calcineurin) transduce signals to the nucleus
• Nucleus: Calcium-dependent transcription factors (NFAT, CREB) regulate gene expression
• Mitochondria: Calcium uptake via MCU regulates metabolism and apoptosis

CACNG1 in Synaptic Transmission

In hippocampal and cortical neurons, L-type channels containing gamma auxiliary subunits contribute to:

• Dendritic calcium influx: L-type channels in dendritic shafts and spines generate localized calcium signals
• Synaptic plasticity: Calcium through L-type channels can trigger molecular cascades underlying learning and memory[@snider2018]
• Homeostatic regulation: Calcium influx through L-type channels participates in homeostatic scaling of synaptic strength

Disease Associations

Alzheimer's Disease (AD)

Calcium dysregulation is increasingly recognized as a central feature of AD pathophysiology[@snyder2022], [@kevich2020]:

• Amyloid-beta effects: Aβ oligomers dysregulate L-type calcium channels, leading to abnormal calcium influx
• Tau pathology: Hyperphosphorylated tau disrupts calcium channel localization and function
• Calpain activation: Excessive calcium influx activates calpains, which cleave tau and other substrates[@calpain2021]
• ER stress: Calcium dysregulation triggers endoplasmic reticulum stress and the unfolded protein response
• Synaptic failure: Calcium dysregulation contributes to early synaptic dysfunction in AD

Parkinson's Disease (PD)

Dopaminergic neurons of the substantia nigra pars compacta exhibit distinctive calcium handling properties[@chan2018]:

• Pacemaking activity: These neurons rely on L-type (Cav1.3) calcium channels for autonomous rhythmic firing
• Calcium load: Sustained calcium influx during pacemaking creates metabolic stress
• Mitochondrial calcium: Calcium uptake by mitochondria during pacemaking affects bioenergetics
• Oxidative stress: Calcium-dependent processes increase [reactive oxygen species (ROS)Productions]

Epilepsy

Mutations in voltage-gated calcium channel genes are established causes of genetic epilepsy syndromes[@gomez2021]:

• CACNA1A: P/Q-type channel, causes familial hemiplegic migraine and epilepsy
• CACNB4: Beta-4 subunit, causes absence epilepsy and juvenile myoclonic epilepsy
• CACNG1: Potential role as a modulator of neuronal excitability through L-type channel effects

Neuromuscular Disorders

The high skeletal muscle expression of CACNG1 links it to neuromuscular biology[@awa2018]:

• Neuromuscular junction: L-type calcium channels at the motor endplate mediate excitation-contraction coupling
• Congenital myasthenic syndromes: Some calcium channel subunit mutations cause fatigable weakness
• Muscular dystrophy: Calcium dysregulation contributes to muscle fiber damage

Therapeutic Implications

Calcium Channel Blockers in Neurodegeneration

Calcium channel blockers (CCBs) have been investigated as disease-modifying agents in neurodegenerative conditions[@nimmrich2015], [@fernandez2018]:

• Isradipine: Dihydropyridine L-type calcium blocker showed promise in PD models by reducing dopaminergic neuron calcium load
• Nimodipine: L-type CCB with CNS penetration, studied in AD and vascular cognitive impairment
• Diltiazem/verapamil: Non-dihydropyridine CCBs with different channel subunit selectivity

Targeting Auxiliary Subunits

The auxiliary subunits offer potential drug targets because[@awa2018], [@taylor2019]:

Expression Pattern

CACNG1 shows tissue-specific expression with notable differences between central and peripheral tissues[@awa2018]:

• Skeletal muscle: Highest expression; associated with T-tubule L-type calcium channels (Cav1.1)
• Cardiac muscle: Moderate expression; contributes to cardiac L-type channels (Cav1.2)
• Brain: Lower expression but with regional specificity; associated with neuronal Cav1.2 and Cav1.3
• Spinal cord: Detected in motor neurons and interneurons
• Peripheral ganglia: Expression in sensory and autonomic neurons

• Cerebral cortex (layer V pyramidal neurons)
• Hippocampus (CA1-CA3 pyramidal neurons)
• Cerebellum (Purkinje cells)
• Brainstem motor nuclei
• Basal ganglia structures

Interaction Network

CACNG1 interacts with multiple proteins within the calcium channel complex[@pierce2020], [@bergerton2019]:

| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| Cav1.2 (CACNA1C) | Alpha-1 subunit | Primary pore-forming partner in neuronal L-type channels |
| Cav1.3 (CACNA1D) | Alpha-1 subunit | Expressed in dopaminergic neurons and endocrine cells |
| Cav1.1 (CACNA1S) | Alpha-1 subunit | Skeletal muscle E-C coupling |
| CACNB1-4 | Beta subunit | Coregulation of channel assembly and trafficking |
| CACNA2D1-4 | Alpha-2/delta subunit | Channel surface expression and modulation |
| Ryr2 | Ryanodine receptor | Calcium release from sarcoplasmic reticulum |
| CaM | Calmodulin | Calcium-dependent inactivation of channel |

Research History

| Year | Milestone |
|------|-----------|
| 1990s | CACNG1 gene cloned and identified as L-type calcium channel gamma subunit |
| 2000 | Gamma subunit transmembrane topology determined |
| 2005 | Identification of gamma subunit effects on channel trafficking |
| 2010 | First genetic associations between calcium channel subunits and neurodegeneration |
| 2015 | Gamma subunits implicated in neuronal calcium dynamics |
| 2018 | Comprehensive review of calcium channel gamma subunits in neurological disease[@awa2018] |
| 2019 | CACNG1 variants associated with neurodegenerative disease risk[@erickson2021] |
| 2020 | Structural studies of auxiliary subunit interactions[@pierce2020] |
| 2022 | L-type calcium channel-targeted therapies in PD clinical trials[@morris2022] |

See Also

• [Ion Channels](/mechanisms/ion-channels)
• [Calcium Signaling in Neurodegeneration](/mechanisms/calcium-dysregulation-neurodegeneration)
• [L-type Calcium Channels](/mechanisms/l-type-calcium-channels)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
• [Neuroprotection](/mechanisms/neuroprotection)

External Links

• [NCBI Gene: CACNG1](https://www.ncbi.nlm.nih.gov/gene/11052)
• [UniProt: Q9Y698](https://www.uniprot.org/uniprot/Q9Y698)
• [GeneCards: CACNG1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CACNG1)
• [PubMed: CACNG1 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=CACNG1+neurodegeneration)
• [Wikipedia: CACNG1](https://en.wikipedia.org/wiki/CACNG1)